Literature DB >> 3559484

Aminolaevulinate dehydratase porphyria in infancy. A clinical and biochemical study.

S Thunell, L Holmberg, J Lundgren.   

Abstract

Homozygous deficiency of aminolaevulinate dehydratase (porphobilinogen synthase, EC 4.2.1.24) was diagnosed in a small child. The clinical presentation was unique since severe symptoms were already present in the neonatal period. The patient, a boy, now three-years old, had recurrent attacks of pain, vomiting, hyponatraemia and symptoms of polyneuropathy engaging motor functions including respiration. The clinical course of the disease from birth on is related, as are the results of various attempts at therapy. The patient excreted large amounts of 5-aminolaevulinic acid and coproporphyrin and minor amounts of porphobilinogen in the urine. Faecal excretion of coproporphyrin and harderoporphyrin was increased as was erythrocyte porphyrin concentration. Diagnosis was established by the finding that erythrocyte aminolaevulinate dehydratase activity was less than 5 per cent of normal in the patient and between 26 and 51 per cent of normal in both the parents, the grandfathers and a sibling. The activity of the enzyme could not be restored by the addition of dithiothreitol (10(-3) mol/l) alone, or in combination with zinc or manganese in varying concentrations. The enzyme Km did not differ between affected and nonaffected members of the family.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3559484     DOI: 10.1515/cclm.1987.25.1.5

Source DB:  PubMed          Journal:  J Clin Chem Clin Biochem        ISSN: 0340-076X


  13 in total

1.  ALAD porphyria is a conformational disease.

Authors:  Eileen K Jaffe; Linda Stith
Journal:  Am J Hum Genet       Date:  2006-12-21       Impact factor: 11.025

Review 2.  Hepatic porphyria: A narrative review.

Authors:  Sumant Arora; Steven Young; Sudha Kodali; Ashwani K Singal
Journal:  Indian J Gastroenterol       Date:  2016-10-31

Review 3.  Hepatic porphyrias in children.

Authors:  G H Elder
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

4.  delta-Aminolevulinate dehydratase deficient porphyria: identification of the molecular lesions in a severely affected homozygote.

Authors:  M Plewinska; S Thunell; L Holmberg; J G Wetmur; R J Desnick
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

Review 5.  Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias.

Authors:  Vaithamanithi-Mudumbai Sadagopa Ramanujam; Karl Elmo Anderson
Journal:  Curr Protoc Hum Genet       Date:  2015-07-01

6.  Cloning and expression of the defective genes from a patient with delta-aminolevulinate dehydratase porphyria.

Authors:  N Ishida; H Fujita; Y Fukuda; T Noguchi; M Doss; A Kappas; S Sassa
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

Review 7.  The acute hepatic porphyrias.

Authors:  Bruce Wang
Journal:  Transl Gastroenterol Hepatol       Date:  2021-04-05

Review 8.  Porphyrias in Japan: compilation of all cases reported through 2002.

Authors:  Masao Kondo; Yuzo Yano; Masuo Shirataka; Gumpei Urata; Shigeru Sassa
Journal:  Int J Hematol       Date:  2004-06       Impact factor: 2.490

9.  The third case of Doss porphyria (delta-amino-levulinic acid dehydratase deficiency) in Germany.

Authors:  M O Doss; T Stauch; U Gross; M Renz; R Akagi; M Doss-Frank; H P Seelig; S Sassa
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 10.  Novel treatment options for acute hepatic porphyrias.

Authors:  Bruce Wang
Journal:  Curr Opin Gastroenterol       Date:  2021-05-01       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.